Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry for spontaneous coronary artery dissection in Switzerland

Official title: Spontaneous Coronary Artery Dissection (SCAD) National Swiss Registry (SwissSCAD)

Run by University Hospital, Geneva · NCT04457544 · Data updated 2026-11-12

This study is creating a registry to collect information about spontaneous coronary artery dissection in Switzerland to help improve diagnosis and treatment for young women affected by this condition.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorUniversity Hospital, Geneva
Academic / other
Locations1 site (Geneva)
StatusRecruiting
StartedAugust 12, 2020
Main results expectedJune 30, 2025
Study endsJune 30, 2030
Registry record updatedNovember 16, 2022
Trial IDNCT04457544 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18 and older who have been newly diagnosed with SCAD or diagnosed within the last five years.

Probably not a fit

Patients with atherosclerotic or iatrogenic coronary dissection will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a national registry for spontaneous coronary artery dissection (SCAD) in Switzerland. It focuses on understanding the natural history, outcomes, and treatments of SCAD, which primarily affects young women without traditional cardiovascular risk factors. By collecting data from patients diagnosed with SCAD, the registry seeks to improve timely diagnosis and clinical follow-up, addressing the gaps in knowledge surrounding this underdiagnosed condition. The study will include patients who are newly diagnosed or diagnosed within the last five years.

Why it matters

Potential benefit: If successful, this registry could lead to improved diagnosis and management of SCAD, ultimately reducing adverse cardiac outcomes.

How similar studies have gone: While SCAD is a relatively underexplored area, the establishment of registries has shown promise in other conditions, suggesting potential for success in this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject is ≥18 years of age.
* Patient presenting newly diagnosed SCAD or diagnosed with SCAD within the last 5 years.
* Subject must be willing to sign a Patient Informed Consent (PIC).

Exclusion Criteria:

* Patient unwilling or unable to provide informed consent.
* Patients with atherosclerotic or iatrogenic coronary dissection.

Where it's running

  • Geneva University Hospitals
    Geneva, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.